HALOZYME THERAPEUTICS INC: Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in HALOZYME THERAPEUTICS INC. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
4
13F filers
Aggregate Value
$30.5M
Across holders
Last Price
—
EOD close
Sector
—
GICS
Quarterly fund activity0 increased2 reduced0 exited
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 11.94M | $13.3M | 43.6% | 0.0% | Reduced | $-8.4M | Q2 2026 |
| Point72 Asset Management, L.P. CIK 0001603466 | Hedge Fund | 7.50M | $8.4M | 27.4% | 0.0% | Unchanged | +$0 | Q2 2026 |
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 6.20M | $6.9M | 22.7% | 0.0% | Unchanged | +$0 | Q2 2026 |
| Man Group plc CIK 0001637460 | Hedge Fund | 1.73M | $1.9M | 6.3% | 0.0% | Reduced | $-145K | Q2 2026 |
Reduced
Hedge Fund
$13.3M· 43.6% of total· 0.0% port· 11.94M sh· $-8.4M QoQ· Q2 2026
Unchanged
Hedge Fund
$8.4M· 27.4% of total· 0.0% port· 7.50M sh· +$0 QoQ· Q2 2026
Unchanged
Hedge Fund
$6.9M· 22.7% of total· 0.0% port· 6.20M sh· +$0 QoQ· Q2 2026
Reduced
Hedge Fund
$1.9M· 6.3% of total· 0.0% port· 1.73M sh· $-145K QoQ· Q2 2026